CytoVeris has a total of 31 patents globally, out of which 4 have been granted. Of these 31 patents, more than 74% patents are active. The United States of America is where CytoVeris has filed the maximum number of patents, followed by Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of CytoVeris.
CytoVeris was founded in 2018. CytoVeris offers instruments for cancer surgery. During operation, the company helps cancer doctors distinguish between healthy and cancerous tissue in real time.
Do read about some of the most popular patents of CytoVeris which have been covered by us in this article and also you can find CytoVeris patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over CytoVeris patent portfolio.
How many patents do the Founder and CEO of CytoVeris have?
The Founder and CEO Alan Kersey have 47 patents.
How many patents does CytoVeris have?
CytoVeris has a total of 31 patents globally. These patents belong to 21 unique patent families. Out of 31 patents, 23 patents are active.
How Many Patents did CytoVeris File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | CytoVeris Applications Filed | CytoVeris Patents Granted |
2023 | 2 | 2 |
2022 | 7 | 1 |
2021 | 14 | 1 |
2020 | 8 | – |
How many CytoVeris patents are Alive/Dead?
Worldwide Patents
How Many Patents did CytoVeris File in Different Countries?
Countries in which CytoVeris Filed Patents
Country | Patent |
United States of America | 17 |
Europe | 4 |
List of CytoVeris patents
CytoVeris Patents | Title |
US11725984B2 | Raman Spectroscopy-Based Optical Matched Filter System And Method For Using The Same |
US11686684B2 | Raman Spectroscopy Based Assay For Both Low And High Abundant Biomolecules In A Biological Fluid Sample |
US11441949B2 | Method And Apparatus For Identifying A Raman Spectrum From Background Fluorescence |
US11193827B2 | Method And Apparatus For Identifying Background Fluorescence Using Spread Spectrum Excitation-Source Broadening In Raman Spectroscopy |
US20230324300A1 | Autofluorescence-Based Biomolecular Barcode Approach For Tissue Classification |
US20230296519A1 | Autofluorescence-Based Targeting Of Pathologically/Diagnostically Relevant Tissue Regions For Efficient And Accurate Omics Profiling |
US20230266170A1 | Spectrometer-Less Sample Analysis System And Method Using High Wavenumber Raman Scattering |
US20230162410A1 | Multi-Spectral Auto-Fluorescence Based Stainless And Slide-Free Virtual Histology |
US20220317046A1 | Digital Mirror Device Based Code-Division Multiplexed Raman Optical Mapping System For Wide Field Imaging |
US20220284603A1 | System And Method For Producing An Image-Based Registration Of Surgically Excised Tissue Specimens |
US20220283092A1 | Method And System For Identifying Tissue Type Based On Peak-Fitted Parameters In High-Wavenumber Raman Spectrum |
US20220283093A1 | System And Method For Classification Of Tissue Based On Raman And Fluorescence In High-Wavenumber Raman Spectrum |
US20220196557A1 | Angular Depth Resolved Raman Spectroscopy Apparatus And Method |
US20220099580A1 | Method And System For Detecting Cancerous Tissue And Tumor Margin Using Raman Spectroscopy |
US20220079450A1 | Method And Probe System For Tissue Analysis In A Surgical Cavity In An Intraoperative Procedure |
US20220065791A1 | Stimulated Raman Spectroscopy Based Multiplexed Virtual Immunohistology Using Alkynic, Nitrile, Or Azide Probes |
US20210325302A1 | Determination Of Margin In Freshly Resected Tissue Specimens Using Tumor Responsive Tissue Marking Dye |
EP4214487A1 | Multi-Spectral Imager For Uv-Excited Tissue Autofluorescence Mapping |
EP4185859A1 | Spectrometer-Less Sample Analysis System And Method Using High Wavenumber Raman Scattering |
EP4097455A1 | Apparatus And Method For Detecting And Treating Cancerous Tissue Using Raman Spectroscopy And Hyperthermia |
EP3917382A4 | Method And System For Detecting Cancerous Tissue And Tumor Margin Using Raman Spectroscopy |
WO2023278673A1 | Method And Apparatus For Mitigating Specular Highlights In Imaging Of Biological Tissue |
WO2022261106A1 | A Smart Tissue Classification Framework Based On Multi-Classifier Systems |
WO2022150408A1 | Multi-Modal Multi-Spectral Imaging System And Method For Characterizing Tissue Types In Bladder Specimens |
WO2022061186A1 | Multi-Spectral Imager For Uv-Excited Tissue Autofluorescence Mapping |
WO2022020807A1 | Spectrometer-Less Sample Analysis System And Method Using High Wavenumber Raman Scattering |
WO2021216740A1 | Uv Excited Multi Spectral Fluorescence Based Tissue Analysis With Raman Spectroscopy Zoom-In Scanning |
WO2021155375A1 | Apparatus And Method For Detecting And Treating Cancerous Tissue Using Raman Spectroscopy And Hyperthermia |
WO2021011823A1 | Digital Mirror Device Based Code-Division Multiplexed Raman Optical Mapping System For Wide Field Imaging |
WO2020206420A1 | Angular Depth Resolved Raman Spectroscopy Apparatus And Method |
WO2020160462A1 | Method And System For Detecting Cancerous Tissue And Tumor Margin Using Raman Spectroscopy |
What are CytoVeris key innovation segments?
What Technologies are Covered by CytoVeris?
The chart below distributes patents filed by CytoVeris